Paper32045136
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results.
Cortesi L and 23 others. Cancer Med, 2020. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results. Papers, record 32045136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32045136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Breast Neoplasms | Major topic |
| Early Detection of Cancer | Major topic |
| Genetic Predisposition to Disease | Major topic |
| Genetic Testing | Major topic |
| Mutation | Major topic |
| Adult | |
| Aged | |
| BRCA1 Protein | |
| BRCA2 Protein | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Italy | |
| Middle Aged | |
| Prognosis |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06629896 | Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled Trial | Results |
Source ClinicalTrials.gov
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27045154 | Identifying Women at Risk for Hereditary Breast and Ovarian Cancer Syndrome Utilizing Breast Care Nurse Navigation at Mammography and Imaging Centers. | J Natl Black Nurses Assoc | 2015 | https://conductscience.org/library/papers/27045154 | PubMed |
| 2 | 27737975 | Identification and management of women with a family history of breast cancer: Practical guide for clinicians. | Can Fam Physician | 2016 | https://conductscience.org/library/papers/27737975 | PubMed |
| 3 | 11044645 | BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer. | Eur J Cancer | 2000 | https://conductscience.org/library/papers/11044645 | PubMed |
| 4 | 29361001 | Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women. | J Natl Cancer Inst | 2018 | https://conductscience.org/library/papers/29361001 | PubMed |
| 5 | 25394175 | A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. | Genet Med | 2015 | https://conductscience.org/library/papers/25394175 | PubMed |
| 6 | 14627668 | Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. | J Med Genet | 2003 | https://conductscience.org/library/papers/14627668 | PubMed |
| 7 | 9012404 | Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. | Am J Hum Genet | 1997 | https://conductscience.org/library/papers/9012404 | PubMed |
| 8 | 30288491 | Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition. | Eur J Breast Health | 2018 | https://conductscience.org/library/papers/30288491 | PubMed |
| 9 | 29173497 | Breast cancer genetics in young women: What do we know? | Mutat Res Rev Mutat Res | 2017 | https://conductscience.org/library/papers/29173497 | PubMed |
| 10 | 20065170 | American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20065170 | PubMed |
| 11 | 24945890 | Multiple primary cancers as a guide to heritability. | Int J Cancer | 2014 | https://conductscience.org/library/papers/24945890 | PubMed |
| 12 | 23213100 | Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23213100 | PubMed |
| 13 | 30152102 | Hereditary cancer screening: Case reports and review of literature on ten Ashkenazi Jewish founder mutations. | Mol Genet Genomic Med | 2018 | https://conductscience.org/library/papers/30152102 | PubMed |
| 14 | 31171119 | Hereditary Cancer Syndromes-A Primer on Diagnosis and Management: Part 1: Breast-Ovarian Cancer Syndromes. | Mayo Clin Proc | 2019 | https://conductscience.org/library/papers/31171119 | PubMed |
| 15 | 2322650 | Clinical/genetic features in hereditary breast cancer. | Breast Cancer Res Treat | 1990 | https://conductscience.org/library/papers/2322650 | PubMed |
| 16 | 22527108 | Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy. | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/22527108 | PubMed |
| 17 | 11151059 | Hereditary cancer syndromes. | Arch Pathol Lab Med | 2001 | https://conductscience.org/library/papers/11151059 | PubMed |
| 18 | 27906166 | Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations. | Genet Med | 2016 | https://conductscience.org/library/papers/27906166 | PubMed |
| 19 | 21720365 | Integrated genomic analyses of ovarian carcinoma. | Nature | 2011 | https://conductscience.org/library/papers/21720365 | PubMed |
| 20 | 9382137 | Psychological aspects of genetic counseling. XI. Nondirectiveness revisited. | Am J Med Genet | 1997 | https://conductscience.org/library/papers/9382137 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41251891 | "Would you want to know?" Questions of utility and responsibility in Italian laypersons' preferences about genetic risk communication. | J Community Genet | 2025 | https://conductscience.org/library/papers/41251891 | PubMed |
| 39195440 | Evaluation of an Italian Population-Based Programme for Risk Assessment and Genetic Counselling and Testing for BRCA1/2-Related Hereditary Breast and Ovarian Cancer after 10 Years of Operation: An Observational Study Protocol. | Methods Protoc | 2024 | https://conductscience.org/library/papers/39195440 | PubMed |
| 38362558 | European validation of an image-derived AI-based short-term risk model for individualized breast cancer screening-a nested case-control study. | Lancet Reg Health Eur | 2024 | https://conductscience.org/library/papers/38362558 | PubMed |
| 37968543 | Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention? | Fam Cancer | 2024 | https://conductscience.org/library/papers/37968543 | PubMed |
| 37046793 | Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37046793 | PubMed |
| 35406409 | Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35406409 | PubMed |
| 34669096 | Identification of women at risk of hereditary breast-ovarian cancer among participants in a population-based breast cancer screening. | Fam Cancer | 2022 | https://conductscience.org/library/papers/34669096 | PubMed |
| 34363132 | Five-year annual incidence and clinico-molecular features of breast cancer after the last negative screening mammography at age 68-69. | Eur Radiol | 2022 | https://conductscience.org/library/papers/34363132 | PubMed |
| 33710534 | An Overview of PARP Inhibitors for the Treatment of Breast Cancer. | Target Oncol | 2021 | https://conductscience.org/library/papers/33710534 | PubMed |
| 32045136 | A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results. | Cancer Med | 2020 | https://conductscience.org/library/papers/32045136 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| BRIP1 | 83990 | PubTator's text mining | https://conductscience.org/library/genes/83990 | NCBI Gene |
| ELAVL2 | 1993 | PubTator's text mining | https://conductscience.org/library/genes/1993 | NCBI Gene |
| PALB2 | 79728 | PubTator's text mining | https://conductscience.org/library/genes/79728 | NCBI Gene |
| RAD51C | 5889 | PubTator's text mining | https://conductscience.org/library/genes/5889 | NCBI Gene |
| RAD51D | 5892 | PubTator's text mining | https://conductscience.org/library/genes/5892 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32045136
GET https://conductscience.org/api/papers/v1/32045136/authors?page=2